Adeeva Bone Support
Natural health product licensed in Canada
- Licence holder
- Adeeva Nutritionals Canada Inc.
- NPN or DIN-HM
- 80135576
- Status
- Active licence
- Licence date
- 31 October 2024
- Revision date
- 16 March 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- À vérifier
Magnésium: up to 300 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Beta vulgaris - Racine | 5 mg | Not calculated |
| Epimedium sagittatum Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 10 Microgrammes | Not calculated |
| Magnésium Source : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH) | 150 mg | 300,000 µg |
| Calcium Source : Citrate de calcium | 300 mg | 600,000 µg |
| Calcium Source : Carbonate de calcium | 300 mg | 600,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Amidon de riz, Triglycérides à chaîne moyenne, Croscarmellose de sodium, Hypromellose, Acide stéarique, Stéarate de magnésium, Isomalt
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in bone development. Helps maintain/support bone health. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Vitamin and mineral supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80135576
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.